>Mercado de solventes farmacêuticos da América do Norte, por produto (álcool, amina, ésteres, éteres, hidrocarbonetos aromáticos, solventes clorados, cetonas e outros), aplicações (farmacêutico, laboratórios de investigação, produtos químicos e outros), país (EUA, Canadá e México) ) Tendências de mercado e previsão para 2028.
Análise de Mercado e Insights: Mercado de Solventes Farmacêuticos da América do Norte
Espera-se que o mercado norte-americano de solventes farmacêuticos ganhe um crescimento significativo no período de previsão de 2021 a 2028. A Data Bridge Market Research analisa que o mercado está a crescer a um CAGR de 4,6% no período de previsão de 2021 a 2028 e deverá atingir os 2.271.558,55 mil dólares até 2028.
Os solventes farmacêuticos referem-se a compostos químicos, principalmente utilizados no fabrico de medicamentos na indústria farmacêutica. Estes solventes são utilizados na dissolução de outros produtos e componentes, encontrando a sua utilização como bloco de fabrico, fornecendo as moléculas necessárias na produção de medicamentos e produtos farmacêuticos. Estes solventes são também utilizados no processo de extração e purificação. A maioria dos solventes farmacêuticos não pode ser completamente removida dos medicamentos finais. É, no entanto, desejado que um solvente farmacêutico não altere as propriedades de qualquer um dos produtos químicos envolvidos na reacção.
Estes solventes alcoólicos são utilizados em vários medicamentos farmacêuticos importantes, como o glicol , o isopropanol e o etanol, e o crescimento do setor farmacêutico e da saúde são os principais fatores que impulsionam o crescimento do mercado. Além disso, os elevados custos de produção e o complexo processo de fabrico funcionam como uma restrição ao crescimento do mercado. Por outro lado, as crescentes atividades de investigação e desenvolvimento e o desenvolvimento de novos métodos e tecnologias de produção de medicamentos funcionam como uma oportunidade para o mercado. No entanto, o aumento das preocupações com a toxicidade dos solventes pode criar ainda mais desafios para o crescimento do mercado.
O relatório do mercado de solventes farmacêuticos da América do Norte fornece detalhes de quota de mercado, novos desenvolvimentos e análise de pipeline de produtos, o impacto dos participantes do mercado doméstico e localizado, analisa as oportunidades em termos de bolsas de receitas emergentes, mudanças nas regulamentações de mercado, aprovações de produtos, decisões estratégicas, lançamentos de produtos, expansões geográficas e inovações tecnológicas no mercado. Para compreender a análise e o panorama global do mercado de solventes farmacêuticos, contacte a Data Bridge Market Research para obter um resumo dos analistas; a nossa equipa irá ajudá-lo a criar uma solução de impacto na receita para atingir a meta desejada.
Âmbito do mercado de solventes farmacêuticos da América do Norte e dimensão do mercado
O mercado norte-americano de solventes farmacêuticos está segmentado em dois segmentos notáveis, que são baseados no produto e na aplicação. O crescimento entre segmentos ajuda-o a analisar os nichos de crescimento e as estratégias para abordar o mercado e determinar as suas principais áreas de aplicação e a diferença nos seus mercados-alvo.
- Com base no produto, o mercado norte-americano de solventes farmacêuticos está segmentado em álcool, amina, ésteres, éteres, hidrocarbonetos aromáticos, solventes clorados, cetonas, entre outros. Em 2021, espera-se que o segmento do álcool domine o mercado norte-americano de solventes farmacêuticos, uma vez que o solvente alcoólico dissolve os medicamentos sem alterar a composição e a adição tem várias ações farmacológicas dependentes da concentração, incluindo sedativo, carminativo, refrescante , antipirético, rubefaciente, limpeza e propriedades anti-sépticas.
- Com base na aplicação, o mercado norte-americano de solventes farmacêuticos está segmentado em Farmacêuticos, Laboratórios de Investigação , Químicos, entre outros. Em 2021, prevê-se que o segmento farmacêutico domine o mercado, uma vez que o solvente alcoólico tem uma vasta utilização na região como desinfetante e higienizante tópico.
Análise a nível de país do mercado de solventes farmacêuticos
O mercado da América do Norte é analisado e são fornecidas informações sobre o tamanho do mercado por produto e aplicação. Os países abordados no relatório sobre o mercado de solventes farmacêuticos da América do Norte são os EUA, o Canadá e o México. A América do Norte está a dominar o mercado devido ao crescente setor farmacêutico e de saúde na região.
Mercado de solventes farmacêuticos, por aplicação
A secção do país do relatório também fornece fatores individuais de impacto no mercado e alterações na regulamentação do mercado interno que impactam as tendências atuais e futuras do mercado. Dados como novas vendas, vendas de reposição, demografia do país, atos regulamentares e tarifas de importação e exportação são alguns dos principais indicadores utilizados para prever o cenário de mercado para países individuais. Além disso, a presença e a disponibilidade das marcas da América do Norte e os desafios enfrentados devido à concorrência grande ou escassa de marcas locais e nacionais, o impacto dos canais de vendas são considerados, ao mesmo tempo que fornece uma análise de previsão dos dados do país.
O crescimento da investigação e desenvolvimento médico está a impulsionar o crescimento do mercado norte-americano de solventes farmacêuticos
O mercado de solventes farmacêuticos da América do Norte também fornece análises de mercado detalhadas para o crescimento de cada país na base instalada de diferentes tipos de produtos para o mercado, impacto da tecnologia utilizando curvas de linha de vida e mudanças nos cenários regulamentares de fórmulas infantis e o seu impacto no mercado. Os dados estão disponíveis para o período histórico de 2011 a 2019.
Análise do cenário competitivo e da quota de mercado dos solventes farmacêuticos
O panorama competitivo do mercado norte-americano de solventes farmacêuticos fornece detalhes por concorrente. Os detalhes incluídos são a visão geral da empresa, finanças da empresa, receitas geradas, potencial de mercado, investimento em investigação e desenvolvimento, novas iniciativas de mercado, presença global, localizações e instalações de produção, pontos fortes e fracos da empresa, lançamento de produtos , pipeline de ensaios clínicos, análise de marca, aprovações de produtos , patentes, largura e amplitude do produto, domínio de aplicação e curva de segurança da tecnologia. Os dados fornecidos acima estão apenas relacionados com o foco das empresas relacionado com o mercado de solventes farmacêuticos da América do Norte.
Os principais players envolvidos no mercado global de solventes farmacêuticos são a Dupont, Mitsui Chemicals, DOW, Brenntag SE, Merck KGaA, Royal Dutch Shell Plc, BASF SE, Exxon Mobil Corporation, Clariant, Eastman Chemical Company, LyondellBasell Industries Holdings BV, Olin Corporation, SK geo centric Co., Ltd., Avantor, Inc., entre outros
Por exemplo,
- Em julho de 2021, a DuPont concluiu a aquisição da Laird Performance Materials, líder mundial em blindagem eletromagnética de alto desempenho e soluções de gestão térmica. Isto ajudará a empresa a expandir a sua base de clientes e a escala global para aumentar a velocidade de entrada no mercado.
SKU-
Obtenha acesso online ao relatório sobre a primeira nuvem de inteligência de mercado do mundo
- Painel interativo de análise de dados
- Painel de análise da empresa para oportunidades de elevado potencial de crescimento
- Acesso de analista de pesquisa para personalização e customização. consultas
- Análise da concorrência com painel interativo
- Últimas notícias, atualizações e atualizações Análise de tendências
- Aproveite o poder da análise de benchmark para um rastreio abrangente da concorrência
Índice
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 PRODUCT LIFE LINE CURVE
2.7 MULTIVARIATE MODELLING
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 MARKET APPLICATION COVERAGE GRID
2.12 DBMR MARKET CHALLENGE MATRIX
2.13 SECONDARY SOURCES
2.14 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 RAW MATERIAL OUTLOOK
4.2 ADOPTION SCENARIO AMONG BUYERS
4.3 VALUE CHAIN ANALYSIS
5 MARKET OVERVIEW
5.1 DRIVERS
5.1.1 GROWTH IN PHARMACEUTICAL, AND HEALTHCARE SECTOR ACROSS THE GLOBE
5.1.2 RISE IN PRODUCTION OF INNOVATIVE GENERIC DRUGS, PARTICULARLY IN EMERGING ECONOMIES
5.1.3 INCREASE IN DEMAND FOR ALCOHOL SOLVENTS FOR MANUFACTURING OF VARIOUS DRUGS
5.2 RESTRAINTS
5.2.1 HIGH PRODUCTION COSTS, AND COMPLEX MANUFACTURING PROCESS
5.2.2 STRINGENT REGULATIONS REGARDING THE USE OF CERTAIN CONVENTIONAL SOLVENTS
5.3 OPPORTUNITIES
5.3.1 GROWTH IN RESEARCH AND DEVELOPMENT ACTIVITIES
5.3.2 DEVELOPMENT OF NEW DRUG MANUFACTURING METHODS AND TECHNOLOGIES
5.3.3 RISE IN ADOPTION OF GREEN MATERIALS AND CHEMICALS FOR DRUG MANUFACTURING
5.4 CHALLENGES
5.4.1 RISE IN CONCERNS REGARDING THE TOXICITY OF SOLVENTS
5.4.2 OCCURRENCES OF FATALITIES IN THE PHARMACEUTICAL SOLVENT MANUFACTURING COMPANIES
6 ANALYSIS ON IMPACT OF COVID-19 ON THE MARKET
6.1 AFTERMATH OF COVID-19 AND THE GOVERNMENT INITIATIVE TO BOOST THE MARKET
6.2 STRATEGIC DECISIONS OF MANUFACTURERS AFTER COVID-19 TO GET COMPETITIVE MARKET SHARE
6.3 IMPACT ON PRICE
6.4 IMPACT ON DEMAND
6.5 IMPACT ON SUPPLY CHAIN
6.6 CONCLUSION
7 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT
7.1 OVERVIEW
7.2 ALCOHOL
7.2.1 METHANOL
7.2.2 ETHANOL
7.2.3 1-BUTANOL
7.2.4 2-BUTANOL
7.2.5 2-METHOXYETHANOL
7.2.6 3-METHYL-1-PROPANOL
7.2.7 2-METHYL-1-PROPANOL
7.2.8 1-PENTANOL
7.2.9 1-PROPANOL
7.2.10 2-PROPANOL (ISOPROPYL ALCOHOL)
7.2.11 OTHERS
7.3 AROMATIC HYDROCARBONS
7.3.1 TOLUENE
7.3.2 XYLENE
7.3.3 ETHYLBENZENE
7.3.4 OTHERS
7.4 KETONES
7.4.1 ACETONE
7.4.2 CYCLOHEXANONE
7.4.3 METHYL ETHER KETONE
7.4.4 METHYL ETHYL KETONE
7.4.5 METHYL ISOBUTYL KETONE
7.4.6 OTHERS
7.5 ETHERS
7.5.1 DIETHYL ETHER
7.5.2 METHOXYETHANE
7.5.3 TETRAHYDROFURAN
7.5.4 METHYL TERT-BUTYL ETHER
7.5.5 DI-N-PROPYL ETHER
7.5.6 OTHERS
7.6 AMINE
7.6.1 MONOETHANOLAMINE (MEA)
7.6.2 DIETHANOLAMINE (DEA)
7.6.3 METHYLDIETHANOLAMINE (MDEA)
7.6.4 OTHERS
7.7 ESTERS
7.7.1 ACETYL ACETATE
7.7.2 ETHYL ACETATE
7.7.3 BUTYL ACETATE
7.7.4 OTHERS
7.8 CHLORINATED SOLVENTS
7.8.1 TRICHLOROETHYLENE (TCE)
7.8.2 PERCHLOROETHYLENE (PCE)
7.8.3 1,1,1-TRICHLOROETHANE (TCA)
7.8.4 OTHERS
7.9 OTHERS
8 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION
8.1 OVERVIEW
8.2 PHARMACEUTICAL
8.3 RESEARCH LABORATORIES
8.4 CHEMICAL
8.5 OTHERS
9 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET
9.1 NORTH AMERICA
9.1.1 U.S.
9.1.2 CANADA
9.1.3 MEXICO
10 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET: COMPANY LANDSCAPE
10.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
10.2 MERGERS & ACQUISITIONS
10.3 EXPANSION
10.4 NEW PRODUCT DEVELOPMENT
10.5 PARTNERSHIP
10.6 AGREEMENTS
10.7 AWARD AND CERTIFICATION
11 SWOT ANALYSIS
12 COMPANY PROFILE
12.1 ROYAL DUTCH SHELL PLC
12.1.1 COMPANY SNAPSHOT
12.1.2 REVENUS ANALYSIS
12.1.3 COMPANY SHARE ANALYSIS
12.1.4 PRODUCT PORTFOLIO
12.1.5 RECENT DEVELOPMENT
12.2 BASF SE
12.2.1 COMPANY SNAPSHOT
12.2.2 REVENUS ANALYSIS
12.2.3 COMPANY SHARE ANALYSIS
12.2.4 PRODUCT PORTFOLIO
12.2.5 RECENT DEVELOPMENT
12.3 MERCK KGAA
12.3.1 COMPANY SNAPSHOT
12.3.2 REVENUE ANALYSIS
12.3.3 COMPANY SHARE ANALYSIS
12.3.4 PRODUCT PORTFOLIO
12.3.5 RECENT DEVELOPMENT
12.4 EXXON MOBIL CORPORATION
12.4.1 COMPANY SNAPSHOT
12.4.2 REVENUE ANALYSIS
12.4.3 COMPANY SHARE ANALYSIS
12.4.4 PRODUCT PORTFOLIO
12.4.5 RECENT DEVELOPMENT
12.5 BRENNTAG SE
12.5.1 COMPANY SNAPSHOT
12.5.2 REVENUE ANALYSIS
12.5.3 COMPANY SHARE ANALYSIS
12.5.4 PRODUCT PORTFOLIO
12.5.5 RECENT DEVELOPMENT
12.6 DUPONT
12.6.1 COMPANY SNAPSHOT
12.6.2 REVENUS ANALYSIS
12.6.3 PRODUCT PORTFOLIO
12.6.4 RECENT DEVELOPMENTS
12.7 MITSUI CHEMICALS
12.7.1 COMPANY SNAPSHOT
12.7.2 REVENUE ANALYSIS
12.7.3 PRODUCT PORTFOLIO
12.7.4 RECENT DEVELOPMENT
12.8 DOW
12.8.1 COMPANY SNAPSHOT
12.8.2 REVENUS ANALYSIS
12.8.3 PRODUCT PORTFOLIO
12.8.4 RECENT DEVELOPMENT
12.9 LYONDELLBASELL INDUSTRIES HOLDINGS B.V.
12.9.1 COMPANY SNAPSHOT
12.9.2 REVENUS ANALYSIS
12.9.3 PRODUCT PORTFOLIO
12.9.4 RECENT DEVELOPMENT
12.1 CLARIANT AG
12.10.1 COMPANY SNAPSHOT
12.10.2 REVENUE ANALYSIS
12.10.3 PRODUCT PORTFOLIO
12.10.4 RECENT DEVELOPMENT
12.11 AVANTOR, INC.
12.11.1 COMPANY SNAPSHOT
12.11.2 REVENUE ANALYSIS
12.11.3 PRODUCT PORTFOLIO
12.11.4 RECENT DEVELOPMENT
12.12 EASTMAN CHEMICAL COMPANY
12.12.1 COMPANY SNAPSHOT
12.12.2 REVENUS ANALYSIS
12.12.3 PRODUCT PORTFOLIO
12.12.4 RECENT DEVELOPMENT
12.13 OLIN CORPORATION
12.13.1 COMPANY SNAPSHOT
12.13.2 REVENUE ANALYSIS
12.13.3 PRODUCT PORTFOLIO
12.13.4 RECENT DEVELOPMENT
12.14 SK GEO CENTRIC CO., LTD. (A SUBSIDIARY OF SK NORTH AMERICA CHEMICAL)
12.14.1 COMPANY SNAPSHOT
12.14.2 PRODUCT PORTFOLIO
13 QUESTIONNAIRE
14 RELATED REPORTS
Lista de Tabela
TABLE 1 INNOVATORS OF GENERIC DRUGS
TABLE 2 DRUGS DEVELOPMENT IN THE YEAR 2021
TABLE 3 CLASSES OF SOLVENTS AND THEIR HARMFUL EFFECTS
TABLE 4 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 5 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 6 NORTH AMERICA ALCOHOL IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (USD THOUSAND)
TABLE 7 NORTH AMERICA ALCOHOL IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (THOUSAND TONS)
TABLE 8 NORTH AMERICA ALCOHOL IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 9 NORTH AMERICA ALCOHOL IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 10 NORTH AMERICA AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (USD THOUSAND)
TABLE 11 NORTH AMERICA AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (THOUSAND TONS)
TABLE 12 NORTH AMERICA AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 13 NORTH AMERICA AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 14 NORTH AMERICA KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (USD THOUSAND)
TABLE 15 NORTH AMERICA KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (THOUSAND TONS)
TABLE 16 NORTH AMERICA KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 17 NORTH AMERICA KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 18 NORTH AMERICA ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (USD THOUSAND)
TABLE 19 NORTH AMERICA ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (THOUSAND TONS )
TABLE 20 NORTH AMERICA ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 21 NORTH AMERICA ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 22 NORTH AMERICA AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (USD THOUSAND)
TABLE 23 NORTH AMERICA AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (THOUSAND TONS)
TABLE 24 NORTH AMERICA AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 25 NORTH AMERICA AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 26 NORTH AMERICA ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (USD THOUSAND)
TABLE 27 NORTH AMERICA ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (THOUSAND TONS)
TABLE 28 NORTH AMERICA ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 29 NORTH AMERICA ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 30 NORTH AMERICA CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (USD THOUSAND)
TABLE 31 NORTH AMERICA CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (THOUSAND TONS)
TABLE 32 NORTH AMERICA CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 33 NORTH AMERICA CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 34 NORTH AMERICA OTHERS IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (USD THOUSAND)
TABLE 35 NORTH AMERICA CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (THOUSAND TONS)
TABLE 36 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2019-2028 (USD THOUSAND)
TABLE 37 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2019-2028 (THOUSAND TONS)
TABLE 38 NORTH AMERICA PHARMACEUTICAL IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (USD THOUSAND)
TABLE 39 NORTH AMERICA PHARMACEUTICAL IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (THOUSAND TONS)
TABLE 40 NORTH AMERICA RESEARCH LABORATORIES IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (USD THOUSAND)
TABLE 41 NORTH AMERICA RESEARCH LABORATORIES IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (THOUSAND TONS)
TABLE 42 NORTH AMERICA CHEMICAL IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (USD THOUSAND)
TABLE 43 NORTH AMERICA CHEMICAL IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (THOUSAND TONS)
TABLE 44 NORTH AMERICA OTHERS IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (USD THOUSAND)
TABLE 45 NORTH AMERICA OTHERS IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (THOUSAND TONS)
TABLE 46 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET, BY COUNTRY, 2019-2028 (USD THOUSAND)
TABLE 47 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET, BY COUNTRY, 2019-2028 (THOUSAND TONS)
TABLE 48 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 49 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 50 NORTH AMERICA ALCOHOL IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 51 NORTH AMERICA ALCOHOL IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 52 NORTH AMERICA AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 53 NORTH AMERICA AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 54 NORTH AMERICA KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 55 NORTH AMERICA KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 56 NORTH AMERICA ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 57 NORTH AMERICA ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 58 NORTH AMERICA AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 59 NORTH AMERICA AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 60 NORTH AMERICA ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 61 NORTH AMERICA ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 62 NORTH AMERICA CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 63 NORTH AMERICA CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 64 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2019-2028 (USD THOUSAND)
TABLE 65 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2019-2028 (THOUSAND TONS)
TABLE 66 U.S. PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 67 U.S. PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 68 U.S. ALCOHOL IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 69 U.S. ALCOHOL IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 70 U.S. AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 71 U.S. AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 72 U.S. KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 73 U.S. KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 74 U.S. ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 75 U.S. ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 76 U.S. AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 77 U.S. AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 78 U.S. ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 79 U.S. ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 80 U.S. CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 81 U.S. CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 82 U.S. PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2019-2028 (USD THOUSAND)
TABLE 83 U.S. PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2019-2028 (THOUSAND TONS)
TABLE 84 CANADA PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 85 CANADA PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 86 CANADA ALCOHOL IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 87 CANADA ALCOHOL IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 88 CANADA AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 89 CANADA AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 90 CANADA KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 91 CANADA KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 92 CANADA ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 93 CANADA ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 94 CANADA AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 95 CANADA AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 96 CANADA ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 97 CANADA ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 98 CANADA CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 99 CANADA CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 100 CANADA PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2019-2028 (USD THOUSAND)
TABLE 101 CANADA PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2019-2028 (THOUSAND TONS)
TABLE 102 MEXICO PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 103 MEXICO PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 104 MEXICO ALCOHOL IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 105 MEXICO ALCOHOL IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 106 MEXICO AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 107 MEXICO AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 108 MEXICO KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 109 MEXICO KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 110 MEXICO ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 111 MEXICO ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 112 MEXICO AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 113 MEXICO AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 114 MEXICO ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 115 MEXICO ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 116 MEXICO CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 117 MEXICO CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 118 MEXICO PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2019-2028 (USD THOUSAND)
TABLE 119 MEXICO PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2019-2028 (THOUSAND TONS)
Lista de Figura
FIGURE 1 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET: PRODUCT LIFELINE CURVE
FIGURE 7 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET: MULTIVARIATE MODELLING
FIGURE 8 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 9 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET: DBMR POSITION GRID
FIGURE 10 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET: VENDOR SHARE ANALYSIS
FIGURE 11 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 12 NORTH AMERICA PHARMACEUTICAL SOLVENT: THE MARKET CHALLENGE MATRIX
FIGURE 13 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET: SEGMENTATION
FIGURE 14 ASIA-PACIFIC REGION IS EXPECTED TO DOMINATE THE NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET, AND TO GROW WITH THE HIGHEST CAGR FROM 2021 TO 2028
FIGURE 15 THE GROWING PHARMACEUTICAL AND HEALTHCARE SECTOR ACROSS THE GLOBE IS DRIVING THE GROWTH OF THE NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 16 ALCOHOL SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET IN 2021 & 2028
FIGURE 17 VALUE CHAIN OF PHARMACEUTICAL SOLVENT
FIGURE 18 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET
FIGURE 19 WORLDWIDE GDP PER CAPITA INCOME
FIGURE 20 NEW DRUGS APPROVED BY THE U.S. FOOD AND DRUG ADMINISTRATION (2010-2020)
FIGURE 21 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET: BY PRODUCT, 2020
FIGURE 22 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET: BY APPLICATION, 2020
FIGURE 23 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET: SNAPSHOT (2020)
FIGURE 24 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET: BY COUNTRY (2020)
FIGURE 25 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET: BY COUNTRY (2021 & 2028)
FIGURE 26 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET: BY COUNTRY (2020 & 2028)
FIGURE 27 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET: BY PRODUCT (2021-2028)
FIGURE 28 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET: COMPANY SHARE 2020 (%)
Metodologia de Investigação
A recolha de dados e a análise do ano base são feitas através de módulos de recolha de dados com amostras grandes. A etapa inclui a obtenção de informações de mercado ou dados relacionados através de diversas fontes e estratégias. Inclui examinar e planear antecipadamente todos os dados adquiridos no passado. Da mesma forma, envolve o exame de inconsistências de informação observadas em diferentes fontes de informação. Os dados de mercado são analisados e estimados utilizando modelos estatísticos e coerentes de mercado. Além disso, a análise da quota de mercado e a análise das principais tendências são os principais fatores de sucesso no relatório de mercado. Para saber mais, solicite uma chamada de analista ou abra a sua consulta.
A principal metodologia de investigação utilizada pela equipa de investigação do DBMR é a triangulação de dados que envolve a mineração de dados, a análise do impacto das variáveis de dados no mercado e a validação primária (especialista do setor). Os modelos de dados incluem grelha de posicionamento de fornecedores, análise da linha de tempo do mercado, visão geral e guia de mercado, grelha de posicionamento da empresa, análise de patentes, análise de preços, análise da quota de mercado da empresa, normas de medição, análise global versus regional e de participação dos fornecedores. Para saber mais sobre a metodologia de investigação, faça uma consulta para falar com os nossos especialistas do setor.
Personalização disponível
A Data Bridge Market Research é líder em investigação formativa avançada. Orgulhamo-nos de servir os nossos clientes novos e existentes com dados e análises que correspondem e atendem aos seus objetivos. O relatório pode ser personalizado para incluir análise de tendências de preços de marcas-alvo, compreensão do mercado para países adicionais (solicite a lista de países), dados de resultados de ensaios clínicos, revisão de literatura, mercado remodelado e análise de base de produtos . A análise de mercado dos concorrentes-alvo pode ser analisada desde análises baseadas em tecnologia até estratégias de carteira de mercado. Podemos adicionar quantos concorrentes necessitar de dados no formato e estilo de dados que procura. A nossa equipa de analistas também pode fornecer dados em tabelas dinâmicas de ficheiros Excel em bruto (livro de factos) ou pode ajudá-lo a criar apresentações a partir dos conjuntos de dados disponíveis no relatório.
